Robert Coifman is a Rheumatology/Immunology physician. OpenAlex indexes 26 publications with 463 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1122 North High St
Millville, NJ 08332
Telephone
856-825-4100Registry record last updated 7 Aug 2007.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ARS Pharmaceuticals Operations, Inc.Program year20255 payments
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- GENZYME CORPORATIONProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
54.2%Leukotriene Receptor Antagonist24.6%Montelukast Sodium100%Part D≥66 patientsCorticosteroid14.3%Fluticasone Propionate60%Breztri Aerosphere26%Symbicort14%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
35.6%H2 blocker18.3%Famotidine100%Part D≥51 patientsProton pump inhibitor16%Omeprazole42%Pantoprazole Sodium37%Esomeprazole Magnesium20%Part D<11 patients+ 1 more class in this area
Dermatology
10.1%Interleukin-4 Receptor alpha Antagonist4.4%Dupixent Pen100%Part D<11 patientsalpha-Hydroxy Acid2.9%Ammonium Lactate100%Part D≥18 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Tolerance to poison ivy following vaccine delivery by precipitation
Annals of Allergy Asthma & Immunology
2018 - Comparison of a micro-electro-mechanical system airflow sensor with the pneumotach in the forced oscillation technique
Medical Devices Evidence and Research
2018 - Assessment of a Low Cost Thin Film Bidirectional Airflow Probe for Pulmonary Applications
Biochemistry & Physiology Open Access
2015 - Poster 1019: Novel allergy vaccine delivery system for poison ivy urushiol (PI) and peanut (PN)
World Allergy Organization Journal
2014
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”